Literature DB >> 35415395

A Methodological Framework for the Integrated Design of Decision-Intensive Care Pathways-an Application to the Management of COPD Patients.

Carlo Combi1, Barbara Oliboni1, Alessandro Zardini2, Francesca Zerbato1.   

Abstract

Healthcare processes are by nature complex, mostly due to their multidisciplinary character that requires continuous coordination between care providers. They encompass both organizational and clinical tasks, the latter ones driven by medical knowledge, which is inherently incomplete and distributed among people having different expertise and roles. Care pathways refer to planning and coordination of care processes related to specific groups of patients in a given setting. The goal in defining and following care pathways is to improve the quality of care in terms of patient satisfaction, costs reduction, and medical outcome. Thus, care pathways are a promising methodological tool for standardizing care and decision-making. Business process management techniques can successfully be used for representing organizational aspects of care pathways in a standard, readable, and accessible way, while supporting process development, analysis, and re-engineering. In this paper, we introduce a methodological framework that fosters the integrated design, implementation, and enactment of care processes and related decisions, while considering proper representation and management of organizational and clinical information. We focus here and discuss in detail the design phase, which encompasses the simulation of care pathways. We show how business process model and notation (BPMN) and decision model and notation (DMN) can be combined for supporting intertwined aspects of decision-intensive care pathways. As a proof-of-concept, the proposed methodology has been applied to design care pathways related to chronic obstructive pulmonary disease (COPD) in the region of Veneto, in Italy. © Springer International Publishing AG 2017.

Entities:  

Keywords:  Business process model and notation; Care pathways; Decision model and notation; Decision modeling; Healthcare process modeling; Methodological framework

Year:  2017        PMID: 35415395      PMCID: PMC8982764          DOI: 10.1007/s41666-017-0007-4

Source DB:  PubMed          Journal:  J Healthc Inform Res        ISSN: 2509-498X


  35 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  A guideline management system.

Authors:  Paolo Ciccarese; Ezio Caffi; Lorenzo Boiocchi; Silvana Quaglini; Mario Stefanelli
Journal:  Stud Health Technol Inform       Date:  2004

Review 3.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

Review 4.  Computer-interpretable clinical guidelines: a methodological review.

Authors:  Mor Peleg
Journal:  J Biomed Inform       Date:  2013-06-25       Impact factor: 6.317

5.  The SAGE Guideline Model: achievements and overview.

Authors:  Samson W Tu; James R Campbell; Julie Glasgow; Mark A Nyman; Robert McClure; James McClay; Craig Parker; Karen M Hrabak; David Berg; Tony Weida; James G Mansfield; Mark A Musen; Robert M Abarbanel
Journal:  J Am Med Inform Assoc       Date:  2007-06-28       Impact factor: 4.497

6.  COPD prevalence in a north-eastern Italian general population.

Authors:  Massimo Guerriero; Marco Caminati; Giovanni Viegi; Gianenrico Senna; Giancarlo Cesana; Carlo Pomari
Journal:  Respir Med       Date:  2015-05-23       Impact factor: 3.415

7.  Reporting and use of the OECD Health Care Quality Indicators at national and regional level in 15 countries.

Authors:  Alexandru M Rotar; Michael J van den Berg; Dionne S Kringos; Niek S Klazinga
Journal:  Int J Qual Health Care       Date:  2016-03-16       Impact factor: 2.038

8.  Integrated care prevents hospitalisations for exacerbations in COPD patients.

Authors:  A Casas; T Troosters; J Garcia-Aymerich; J Roca; C Hernández; A Alonso; F del Pozo; P de Toledo; J M Antó; R Rodríguez-Roisín; M Decramer
Journal:  Eur Respir J       Date:  2006-04-12       Impact factor: 16.671

9.  Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

Authors:  M L Brantly; L D Paul; B H Miller; R T Falk; M Wu; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1988-08

10.  Healthcare costs of COPD in Italian referral centres: a prospective study.

Authors:  Daniela Koleva; Nicola Motterlini; Paolo Banfi; Livio Garattini
Journal:  Respir Med       Date:  2007-08-06       Impact factor: 3.415

View more
  1 in total

1.  Business Process Model and Notation and openEHR Task Planning for Clinical Pathway Standards in Infections: Critical Analysis.

Authors:  Natalia Iglesias; Jose M Juarez; Manuel Campos
Journal:  J Med Internet Res       Date:  2022-09-15       Impact factor: 7.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.